Home

UnitedHealth Group (UNH)

481.11
-4.93 (-1.01%)

UnitedHealth Group is a leading diversified health and well-being company that provides a wide range of health care products and services

The company operates through two main segments: UnitedHealthcare, which offers health insurance and health services to individuals and businesses, and Optum, which delivers pharmacy care, health management, and technology solutions. UnitedHealth Group focuses on enhancing health care access, improving health outcomes, and optimizing costs through integrated care solutions and data-driven insights. With a commitment to innovation and quality, the company aims to help people live healthier lives while making the health care system work better for everyone.

SummaryNewsPress ReleasesChartHistoricalFAQ
Previous Close486.04
Open483.14
Bid478.85
Ask485.95
Day's Range478.82 - 487.60
52 Week Range436.38 - 630.73
Volume3,680,781
Market Cap440.22B
PE Ratio (TTM)31.04
EPS (TTM)15.5
Dividend & Yield8.400 (1.75%)
1 Month Average Volume5,710,590

News & Press Releases

AM Best Affirms Credit Ratings of UnitedHealth Group Incorporated and Its Subsidiaries
AM Best has affirmed the Long-Term Issuer Credit Ratings (Long-Term ICR) of “a” (Excellent) and the Long- and Short-Term Issuer Credit Ratings (Long-Term IR; Short-Term IR) of UnitedHealth Group Incorporated (UnitedHealth Group) (Minnetonka, MN) [NYSE: UNH]. Concurrently, AM Best has affirmed the Financial Strength Rating (FSR) of A+ (Superior) and the Long-Term ICRs of “aa-” (Superior) of the health and dental insurance subsidiaries of UnitedHealth Group, collectively referred to as UnitedHealthcare. The outlook of these Credit Ratings (ratings) is stable. (See link below for a detailed listing of the companies and ratings.)
By AM Best · Via Business Wire · March 12, 2025
Peering Into UnitedHealth Group's Recent Short Interestbenzinga.com
Via Benzinga · March 12, 2025
10 Health Care Stocks Whale Activity In Today's Sessionbenzinga.com
Via Benzinga · March 11, 2025
Vanguard High Dividend Yield ETF vs Vanguard Dividend Appreciation ETF: Which Is Best for You?fool.com
Vanguard has some excellent dividend ETFs, but they are right for different investors.
Via The Motley Fool · March 11, 2025
If You Invested $1000 In This Stock 20 Years Ago, You Would Have This Much Todaybenzinga.com
Via Benzinga · February 25, 2025
UnitedHealth Group Incorporated Investor News: UNH Investors Are Encouraged to Contact The Rosen Law Firm About Ongoing Investigation of Breaches of Fiduciary Duties by the Directors and Officers – UNH
NEW YORK, March 09, 2025 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces it is investigating potential breaches of fiduciary duties by the directors and officers of UnitedHealth Group Incorporated (NYSEUNH) in connection with a report of an investigation by the United States Department of Justice into UnitedHealth’s billing practices.
By The Rosen Law Firm PA · Via GlobeNewswire · March 9, 2025
Vertex Newly Approved Pain Treatment Lands Higher Cost Tier 3 Placement In UnitedHealth's Optum Rx Formulariesbenzinga.com
Vertex's Journavx, a new non-opioid pain drug, lands Tier 3 on Optum Rx formularies. Vertex reports $2.91 billion Q4 sales.
Via Benzinga · March 7, 2025
2 Dow Stocks to Buy Hand Over Fist in March and 1 to Avoidfool.com
Two of the Dow Jones Industrial Average's 30 components make for no-brainer buys, while another brand-name member continues to suffer from self-inflicted wounds.
Via The Motley Fool · March 6, 2025
Health Insurance Providers Stocks Q4 Highlights: Molina Healthcare (NYSE:MOH)
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the health insurance providers industry, including Molina Healthcare (NYSEMOH) and its peers.
Via StockStory · March 5, 2025
UnitedHealth Group Incorporated Investor News: UNH Investors Are Encouraged to Contact The Rosen Law Firm About Ongoing Investigation of Breaches of Fiduciary Duties by the Directors and Officers – UNH
NEW YORK, March 05, 2025 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces it is investigating potential breaches of fiduciary duties by the directors and officers of UnitedHealth Group Incorporated (NYSEUNH) in connection with a report of an investigation by the United States Department of Justice into UnitedHealth’s billing practices.
By The Rosen Law Firm PA · Via GlobeNewswire · March 5, 2025
False Claims Act Case Against UnitedHealth Faces Dismissal Recommendationbenzinga.com
A Special Master has recommended dismissing the government's False Claims Act case against UnitedHealth, citing insufficient evidence. The government has 14 days to object.
Via Benzinga · March 5, 2025
Biotech Rally Coming In Weeks Ahead?talkmarkets.com
Large cap biopharma and MedTech stocks are leading the healthcare sector higher.
Via Talk Markets · March 4, 2025
Q4 Earnings Highlights: UnitedHealth (NYSE:UNH) Vs The Rest Of The Health Insurance Providers Stocks
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at UnitedHealth (NYSEUNH) and its peers.
Via StockStory · March 4, 2025
These Vanguard ETFs Show Where the Smart Money Is Moving Nowfool.com
Via The Motley Fool · March 3, 2025
2 Top Stocks Beaten Down Near 52-Week Lows That Look Like Bargains Nowfool.com
Via The Motley Fool · March 2, 2025
UnitedHealth Group Incorporated Announcement: UNH Investors Are Encouraged to Contact The Rosen Law Firm About Ongoing Investigation of Breaches of Fiduciary Duties by the Directors and Officers – UNH
NEW YORK, March 02, 2025 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces it is investigating potential breaches of fiduciary duties by the directors and officers of UnitedHealth Group Incorporated (NYSEUNH) in connection with a report of an investigation by the United States Department of Justice into UnitedHealth’s billing practices.
By The Rosen Law Firm PA · Via GlobeNewswire · March 2, 2025
$21 Trillion Wealth-Creating Stocks Are Still Undervalued — Three Big Bargains To Buy Nowbenzinga.com
Despite their impressive performance over the past decade, three of the biggest wealth-creating stocks are still considered undervalued.
Via Benzinga · March 2, 2025
MarketBeat Week in Review – 02/24 - 02/28
Stocks tried to stage a weak rally to close the week but the short-term outlook will continue to be dictated by the uncertainty that is creating volatility
Via MarketBeat · March 1, 2025
UnitedHealth Group Incorporated Announcement: UNH Investors Are Encouraged to Contact The Rosen Law Firm About Ongoing Investigation of Breaches of Fiduciary Duties by the Directors and Officers – UNH
NEW YORK, Feb. 27, 2025 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · February 27, 2025
10 Health Care Stocks Whale Activity In Today's Sessionbenzinga.com
Via Benzinga · February 27, 2025
Prediction: This Artificial Intelligence (AI) Company Will Split Its Stock in 2025fool.com
Via The Motley Fool · February 26, 2025
Healthcare Stocks Decline After Trump Signs Executive Order On Price Transparencybenzinga.com
Shares of major healthcare companies such as The Cigna Group Inc. (NYSECI), Molina Healthcare Inc. NYSE: MOHNYSEMOH)(NYSE: UNHNYSEUNH dropped Wednesday following the signing of an executive order by President Donald Trump aimed at strengthening price transparency regulations in the industry.
Via Benzinga · February 26, 2025
10 Health Care Stocks Whale Activity In Today's Sessionbenzinga.com
Via Benzinga · February 26, 2025
What's Going On With UnitedHealth Today?benzinga.com
UnitedHealth Group Inc. (NYSEUNH) shares are trading lower Tuesday after the Wall Street Journal reported that Senator Chuck Grassley launched an inquiry into the company's Medicare billing practices.
Via Benzinga · February 25, 2025
Myriad Genetics Faces Cost Restructuring As UnitedHealthcare Ends GeneSight Coverage, Appoints New CEObenzinga.com
UnitedHealthcare will stop covering Myriad Genetics' GeneSight test in 2025, impacting $45 million in revenue. Myriad reaffirms guidance and names a new CEO.
Via Benzinga · February 25, 2025